Worldwide research trends in Crohn’s disease treatment over the past 2 decades: a bibliometric analysis by Likang Xu, Jinzhao Zou, Chao Sun, Gong Chen, Sujun Gao, Sujun Gao

Get full text

Epileptic Seizures After Allogeneic Hematopoietic Stem Cell Transplantation by Zhuo Wang, Munan Zhao, Sujun Gao

Get full text

The molecular effects underlying the pharmacological activities of daphnetin by Zhifeng Wei, Na Wei, Long Su, Sujun Gao

Get full text

Evaluating the accuracy of Raman spectroscopy in differentiating leukemia patients from healthy individuals: A systematic review and meta-analysis by Shaotong Li, Sujun Gao, Long Su, Ming Zhang

Get full text

Development of a myelodysplastic/myeloproliferative neoplasm-unclassifiable in a patient with acute myeloid leukemia: a case report and literature review by Meifang Zhao, Jingnan Sun, Shanshan Liu, Hongqiong Fan, Yu Fu, Yehui Tan, Sujun Gao

Get full text

Combination of metagenomic next-generation sequencing and conventional tests unraveled pathogen profiles in infected patients undergoing allogeneic hematopoietic stem cell transpla... by Hongyan Zou, Sujun Gao, Xiaoliang Liu, Yong Liu, Yunping Xiao, Ao Li, Yanfang Jiang

Get full text

IL-24 is the key effector of Th9 cell-mediated tumor immunotherapy by Jintong Chen, Yunwei Zhang, Hua Zhang, Mingyue Zhang, He Dong, Tianxue Qin, Sujun Gao, Siqing Wang

Get full text

TNF-α enhances Th9 cell differentiation and antitumor immunity via TNFR2-dependent pathways by Yuxue Jiang, Jintong Chen, Enguang Bi, Yinghua Zhao, Tianxue Qin, Yiming Wang, Alison Wang, Sujun Gao, Qing Yi, Siqing Wang

Get full text

Pancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma. by Dong Tang, Jingqiu Zhang, Zhongxu Yuan, Jun Gao, Sen Wang, Nianyuan Ye, Ping Li, Sujun Gao, Yi Miao, Daorong Wang, Kuirong Jiang

Get full text

Interleukin-33 Contributes to the Induction of Th9 Cells and Antitumor Efficacy by Dectin-1-Activated Dendritic Cells by Jintong Chen, Yinghua Zhao, Yuxue Jiang, Sujun Gao, Yiming Wang, Dongjiao Wang, Alison Wang, Huanfa Yi, Rui Gu, Qing Yi, Qing Yi, Siqing Wang

Get full text

P785: SIX-MONTH CROVALIMAB EXTENSION IN THE PHASE 3 COMMODORE 3 STUDY: UPDATED EFFICACY AND SAFETY RESULTS IN COMPLEMENT INHIBITOR-NAIVE PATIENTS (PTS) WITH PAROXYSMAL NOCTURNAL HE... by Hui Liu, Linghui Xia, Jianyu Weng, Fengkui Zhang, Chuan He, Sujun Gao, Jinsong Jia, Alice Chang, Wenjin LI, Sasha Sreckovic, Dayu Shi, Zilu Zhang, Rong Fu

Get full text

PB2307: PHARMACOKINETICS, EFFICACY AND SAFETY OF SUBCUTANEOUS VERSUS INTRAVENOUS RITUXIMAB COMBINED WITH CHOP IN CHINESE PATIENTS WITH UNTREATED CD20-POSITIVE DIFFUSE LARGE B CELL... by Yan Gao, Liling Zhang, Sujun Gao, Yu Yang, Qing-Yuan Zhang, Huilai Zhang, Pengcheng He, Fei LI, Hongmei Jing, Susan Grange, Lilian Bu, Qianming Wang, Yanjie Wang, Huiqiang Huang

Get full text

Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells by Yinghua Zhao, Xiao Chu, Jintong Chen, Ying Wang, Sujun Gao, Yuxue Jiang, Xiaoqing Zhu, Guangyun Tan, Wenjie Zhao, Huanfa Yi, Honglin Xu, Xingzhe Ma, Yong Lu, Qing Yi, Siqing Wang

Get full text

P1033: JAKTINIB IN PATIENTS WITH MYELOFIBROSIS WHO WERE REFRACTORY OR RELAPSED TO RUXOLITINIB: A SINGLE-ARM, OPEN-LABEL, MULTICENTER, PHASE 2 STUDY by Yi Zhang, Qike Zhang, Qingchi Liu, Huibing Dang, Sujun Gao, Wei Wang, Hu Zhou, Yuqing Chen, Liangming MA, Jishi Wang, Peng Zhao, Haiping Yang, Qingwei Zhao, Shanshan Suo, Jie Jin

Get full text

Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study by Wei Xu, Shenmiao Yang, Keshu Zhou, Ling Pan, Zengjun Li, Jianfeng Zhou, Sujun Gao, Daobin Zhou, Jianda Hu, Ru Feng, Haiwen Huang, Meng Ji, Haiyi Guo, Jane Huang, William Novotny, Shibao Feng, Jianyong Li

Get full text

ARNT/HIF‐1β links high‐risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myeloma by Chuan Wu, Ting Yang, Yingmin Liu, Yicheng Lu, Yanping Yang, Xiaobo Liu, Xuelian Liu, Long Ye, Yue Sun, Xue Wang, Qingchao Li, Peiyu Yang, Xiaoyuan Yu, Sujun Gao, Shaji Kumar, Fengyan Jin, Yun Dai, Wei Li

Get full text

P1021: JAKTINIB IN PATIENTS WITH MYELOFIBROSIS WHO WERE INTOLERANT TO RUXOLITINIB: AN OPEN-LABEL, SINGLE-ARM PHASE 2B STUDY by Yi Zhang, Hu Zhou, Zhijian Xiao, Minghui Duan, Sujun Gao, Guangsheng He, Hongmei Jing, Junmin LI, Liangming MA, Huanling Zhu, Chunkang Chang, Xin Du, Mei Hong, Xin LI, Qingchi Liu, Wei Wang, Xu Na, Haiping Yang, Qingwei Zhao, Jie Jin

Get full text

Long‐term outcomes of second‐line versus later‐line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis by Yuqin Song, Keshu Zhou, Dehui Zou, Dengju Li, Jianda Hu, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Jie Jin, Fangfang Lv, Ru Feng, Sujun Gao, Daobin Zhou, Constantine S. Tam, David Simpson, Michael Wang, Tycel J. Phillips, Stephen Opat, Cheng Fang, Shaohui Sun, Jun Zhu

Get full text

Selinexor plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma previously treated with an immunomodulatory agent and a proteasome inhibitor (MA... by Lugui Qiu, Zhongjun Xia, Chengcheng Fu, Wenming Chen, Chunkang Chang, Baijun Fang, Gang An, Yongqiang Wei, Zhen Cai, Sujun Gao, Jianyu Weng, Lijuan Chen, Hongmei Jing, Fei Li, Zhuogang Liu, Xiequn Chen, Jing Liu, Aihua Wang, Yang Yu, Wenxi Xiang, Kevin Lynch, Zhinuan Yu, Weijun Fu

Get full text

Ruxolitinib plus steroids for acute graft versus host disease: a multicenter, randomized, phase 3 trial by Liping Dou, Yanli Zhao, Jingjing Yang, Lei Deng, Nan Wang, Xiawei Zhang, Qingyang Liu, Yan Yang, Zhijie Wei, Fuxu Wang, Yifan Jiao, Fei Li, Songhua Luan, Liangding Hu, Sujun Gao, Chuanfang Liu, Xiangjun Liu, Jinsong Yan, Xuejun Zhang, Fang Zhou, Peihua Lu, Daihong Liu

Get full text